iTeos Therapeutics Inc. (ITOS)
NASDAQ: ITOS
· Real-Time Price · USD
10.10
-0.07 (-0.69%)
At close: Jun 16, 2025, 3:59 PM
10.07
-0.25%
After-hours: Jun 16, 2025, 05:05 PM EDT
-0.69% (1D)
| Bid | 10 |
| Market Cap | 386.4M |
| Revenue (ttm) | 35M |
| Net Income (ttm) | -130.81M |
| EPS (ttm) | -3.05 |
| PE Ratio (ttm) | -3.31 |
| Forward PE | -6.36 |
| Analyst | Hold |
| Ask | 10.24 |
| Volume | 795,928 |
| Avg. Volume (20D) | 1,242,590 |
| Open | 10.17 |
| Previous Close | 10.17 |
| Day's Range | 10.05 - 10.20 |
| 52-Week Range | 4.80 - 18.13 |
| Beta | 1.51 |
About ITOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ITOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ITOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+17.94%
ITeos Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+13.44%
ITeos Therapeutics shares are trading higher after the company reported topline interim results from its GALAXIES Lung-201 study of Belrestotug + Dostarlimab.
